Join to View Full Profile
601 Elmwood Ave"# 645"Rochester, NY 14642
Phone+1 585-275-6177
Are you Dr. Wheeler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thurman Wheeler, MD is a board certified neurologist in Rochester, New York. He is currently licensed to practice medicine in New York, Massachusetts, and California. He is an Assistant Professor at University of Rochester School of Medicine.
Education & Training
Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1999 - 2000
University of WashingtonResidency, Neurology, 1996 - 1999- University of Washington School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2001 - Present
MA State Medical License 2013 - 2026
NY State Medical License 2005 - 2014
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 6 citationsCorrection of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy.Ningyan Hu, Eunjoo Kim, Layal Antoury, Thurman M Wheeler
Nature Communications. 2023-04-07 - 18 citationsAntisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophyNingyan Hu, Eunjoo Kim, Layal Antoury, Jia Li, Paloma Gonzalez-Perez
Molecular Therapy. Nucleic Acids. 2021-03-05 - Urine mRNA to identify a novel pseudoexon causing dystrophinopathy.Layal Antoury, Ningyan Hu, Basil T. Darras, Thurman M. Wheeler
Annals of Clinical and Translational Neurology. 2019-05-17
Press Mentions
Researchers Identify Link to Kidney in Myotonic Dystrophy Type 1March 6th, 2025
Fluorescence Light up Potential Antisense Oligo Drugs for MDJanuary 1st, 2019
Fluorescent Muscular Dystrophy Mouse Lights up Potential Antisense Oligo DrugsDecember 13th, 2018- Join now to see all
Grant Support
- Prospective study in myotonic dystrophy to determine extracellular RNA biomarkersMASSACHUSETTS GENERAL HOSPITAL2023–2027
- Prospective study in myotonic dystrophy to determine extracellular RNA biomarkersMASSACHUSETTS GENERAL HOSPITAL2023–2027
- Extracellular RNA biomarkers of myotonic dystrophy type 1MASSACHUSETTS GENERAL HOSPITAL2021–2025
